KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioMarket CapitalizationNet MarginOperating MarginReturn on SalesTimes Interest Earned

Palvella Therapeutics (PVLA) Debt to Equity: 2013-2014

Historic Debt to Equity for Palvella Therapeutics (PVLA) over the last 1 years, with Dec 2014 value amounting to $0.07.

  • Palvella Therapeutics' Debt to Equity fell 98.75% to $0.07 in Q4 2014 from the same period last year, while for Dec 2014 it was $0.07, marking a year-over-year decrease of 98.75%. This contributed to the annual value of $0.07 for FY2014, which is 98.75% down from last year.
  • Palvella Therapeutics' Debt to Equity amounted to $0.07 in Q4 2014, which was up 113.46% from -$0.52 recorded in Q3 2014.
  • Palvella Therapeutics' 5-year Debt to Equity high stood at $5.65 for Q4 2013, and its period low was -$0.52 during Q3 2014.
  • In the last 2 years, Palvella Therapeutics' Debt to Equity had a median value of $0.06 in 2014 and averaged $0.80.
  • Data for Palvella Therapeutics' Debt to Equity shows a maximum YoY slumped of 98.75% (in 2014) over the last 5 years.
  • Quarterly analysis of 2 years shows Palvella Therapeutics' Debt to Equity stood at $5.65 in 2013, then crashed by 98.75% to $0.07 in 2014.
  • Its Debt to Equity was $0.07 in Q4 2014, compared to -$0.52 in Q3 2014 and $0.05 in Q2 2014.